Accendra Health, Inc. (ACH) compared with its closest peers (NVST, PODD, RVTY, GMED, HSIC). Peer set by Wholesale; 10 comparable wholesalers. First-party data.
Envista, Insulet, Revvity, Globus Medical, Bio-Rad Laboratories, West Pharmaceutical Services, MiniMed, Waters and Enovis share Accendra Health's business model, medical devices / life science tools.
| Company | Market Cap | P/E |
|---|---|---|
| Envista Holdings Corp (NVST) | $4.43B | 46.7 |
| Insulet Corporation (PODD) | $10.43B | 34.4 |
| Revvity, Inc. (RVTY) | $14.58B | 61.4 |
| Globus Medical, Inc. (GMED) | $10.49B | 19.6 |
| Henry Schein, Inc. (HSIC) | $10.13B | 25.1 |
| Bio-Rad Laboratories, Inc. (BIO) | $10.45B | 61.9 |
| West Pharmaceutical Services, Inc. (WST) | $24.20B | 42.8 |
| MiniMed Group, Inc. (MMED) | $6.69B | — |
| Waters Corporation (WAT) | $40.61B | 244.5 |
| Enovis Corporation (ENOV) | $1.12B | -1.3 |
| Sector P/E (Consumer Discretionary) | 20.2 |
| Industry P/E (Wholesale) | 23.9 |
ACH overview · ACH earnings · ACH financials · ACH KPIs · ACH documents · ACH ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.